Human Fc receptors in antibody mediated inflammation

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

A series of major Australian discoveries is leading to the development of therapies to treat major inflammatory diseases such as rheumatoid arthritis, lupus and similar autoimmune diseases where there is a significant unmet need for new therapies. A major molecule, caled Fc receptor was discoverd by the researchers who have now found new ways to prevent it activating inflammatory cells and therby preventi tissue destruction.

Funded Activity Details

Start Date: 01-01-2014

End Date: 01-01-2016

Funding Scheme: Project Grants

Funding Amount: $640,824.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Fc receptors | antibody | computational chemistry | immune complex | immune-mediated inflammation | rheumatoid arthritis | thrombosis